September 19, 2015 – The American Food and Drug Administration (FDA) just approved Cariprazine (Vraylar) capsules to treat schizophrenia and bipolar disorder in adults. Schizophrenia is a chronic, severe and disabling brain disorder affecting about one percent of Americans. Typically, …

Cariprazine (Vraylar): New treatment for schizophrenia and bipolar disorder approved Read more »

September 01, 2011 – Asenapine Maleate [Saphris] is used to treat symptoms of schizophrenia and bipolar disorder. The American Food and Drug Administration (FDA) has notified healthcare professionals and patients that serious allergic reactions have been reported with the use …

Drug Safety Communication: Asenapine Maleate [Saphris] Associated with Serious Allergic Reactions Read more »